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Abstract
Lipoid proteinosis is a rare autosomal recessive disease characterized by cutaneous and mucosal lesions and
hoarseness appearing in early childhood that is caused by homozygous or compound heterozygous mutations in
the ECM1 gene located on chromosome 1q21. The aim of the study was to investigate the molecular genetic
defect underlying lipoid proteinosis in a consanguineous Pakistani family.
Methods: Genotyping of seven members of the family was performed by amplifying microsatellite markers, tightly
linked to the ECM1 gene. To screen for mutations in the ECM1 gene, all of its exons and splice junctions were PCR
amplified from genomic DNA and analyzed by SSCP and sequenced directly in an ABI 3130 genetic analyzer.
Results: The results revealed linkage of the LP family to the ECM1 locus. Sequence analysis of the coding exons
and splice junctions of the ECM1 gene revealed a novel homozygous mutation (c.616C > T) in exon 6, predicted to
replace glutamine with stop codon (p.Q206X) at amino acid position 206.
Conclusions: The finding of a novel mutation in Pakistani family extends the body of evidence that supports the
importance of ECM1 gene for the development of lipoid proteinosis.
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Background
Lipoid proteinosis (LP; MIM 247100) also known as
Urbach-Wiethe disease or hyalinosis cutis et mucosae,
was first reported by Urbach and Wiethe, in 1929 [1]. It
is a rare genetic disease, which is inherited in an autoso-
mal recessive fashion. The disease occurs worldwide but
is more common in certain geographical areas such as
the Northern Cape province of South Africa, including
Namaqualand. Clinical heterogeneity is reported in LP
[2], although it usually presents in early childhood with
hoarseness, caused by infiltration of the laryngeal
mucosa [3]. Skin lesions or pox-like scars usually appear
simultaneously or shortly afterwards. Other characteris-
tic findings include the arrangement of ‘beaded’ waxy
papules, known as moniliform blepharosis, which may
be present along the margins of both eyelids [4,5].
Histological and ultra structural examination has
revealed the widespread deposition of hyaline-like mate-
rial and disruption/reduplication of basement membrane
around blood vessels and at the dermal-epidermal junc-
tion, mouth and upper respiratory tract, and other inter-
nal organs [2,6]. Overproduction of normally expressed
non-collagenous protein in the hyaline material has also
been reported [7]. Tongue is often firm and its mobility
may be limited. Other symptoms may include thicken-
ing of frenulum, scarring, warty skin papules, nail dys-
trophy, dental anomalies and some neuropsychiatric
symptoms [8,9]. Molecular genetic studies of LP linked
the disorder to chromosome 1q21.1 [2]. The responsible
gene was identified as ECM1, which encodes for the
glycoprotein extracellular matrix protein 1. To date, sev-
eral mutations in the ECM1 gene have been reported in
unrelated LP families from different geographical areas.
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base.
Methods
Subjects
A consanguineous Pakistani family with autosomal reces-
sive LP was ascertained from Rawalpindi district. Two
individuals (ages 15 and 23 years) in the family were
affected with the disorder (Figure 1). Detailed clinical
examination of all the family members, including affected
individuals (IV-1, IV-2), their parents (III-1, III-2) and
normal siblings (IV-3, IV-4, IV-5), was carried out by a
dermatologist at local Leprosy Hospital. Before the start
of the study, approval was obtained from the Quaid-i-
Azam University institutional review board. In addition,
informed consent was obtained from the family members
who participated in the study. Blood samples from
patients, their parents and 3 unaffected siblings were col-
lected and genomic DNA was extracted by the standard
phenol-chloroform method. DNA samples from 100 eth-
nically matched unrelated normal Pakistani individuals
were also collected as controls.
Genotyping
Genomic DNA from seven individuals of the family was
genotyped using microsatellite markers tightly linked to
the ECM1 gene. Polymorphic microsatellite markers
were polymerase chain reaction (PCR) amplified. Each
reaction was carried out in 10 μl volume containing
1.5 mM MgCl2, 0.6 μM of each primer, 0.2 mM each
dNTPs, 1U Taq DNA polymerase and 1 × PCR buffer
{16 mM (NH4) 2SO4, 67mMTris-HCI (pH 8.8), and
0.01% of the nonionic detergent Tween-20} (Bio-line,
London, UK). Amplification was performed with an
initial denaturation for 5 min at 94°C, followed by 35
cycles of denaturation at 94°C for 45 sec, annealing at
55°C for 45 sec, extension at 72°C for 45 sec and a final
extension at 72°C for 10 min. The PCR products were
separated on 8% non-denaturing polyacrylamide gels
stained with ethidium bromide and alleles were assigned
by visual inspection.
Mutation analysis
For detection of mutation in the ECM1 gene, 8 sets of
primers were used to amplify all coding exons and adja-
cent splice sites by PCR. PCR products were initially
screened for mutations by single stranded conforma-
tional polymorphism (SSCP) analysis. For this, aliquots
of 10 μl of each PCR product was mixed with 10 μl
denaturing solution (95% formamide, 20 mM EDTA pH
8.0, 0.05% xylene-cyanole and 0.05% bromo phenol
blue), heated for 7 min at 95°C in PxE thermal cycler
(Hybaid, Basingstoke, U.K.) and chilled quickly on ice
for 5 min. Denatured DNA was subjected to 8% polya-
crylamide gel electrophoresis (20 × 20 × 0.1 cm) con-
taining 7% glycerol and 1 × tris-borate EDTA (TBE)
Figure 1 Clinical presentation of the lipoid proteinosis patients. (A) A 23 years old patient with yellow-white infiltrates and diffuse
acneiform scars on the face; yellow discolouration of lips is also prominent; (B) Infiltrated skin of the trunk and upper extremities with numerous
scars; (C, D, G, and H) Warty skin, thickening & infiltration on the hands, legs, knees and foot. (E) A 15 years old patient with nodular or diffuse
yellow waxy infiltrates located on the face; pseudo solar elastosis of the cheeks and forehead.
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stained with ethidium bromide (1 μg/ml) in 1 × TBE
buffer for about 5 min and visualized under UV transil-
luminator gel documentation system (Syngene, UK).
The PCR products with mobility shift were then purified
for DNA sequencing using commercially available QIA-
quick PCR Purification Kit (Qiagen, Crawley, U.K.).
Direct sequencing was carried out by using Big Dye
®
Terminator v3.1 cycle sequencing kit in an ABI 3130
genetic analyzer (Applied Biosystems, Foster City, CA,
U.S.A.).
Results
Clinical details
The affected individuals had hoarseness of voice, pseudo-
solar elastosis of the cheeks and forehead and waxy
papules along the margins of eyelids. Progressive thicken-
ing and scarring of the skin and mucous membranes,
hyperkeratosis with warty papules on the palms and dor-
sum of the hands, elbow and knee were also observed.
Mobility of the tongue was limited with yellow discolora-
tion of the lips. The clinical features of LP were identical
in both patients; however, severity was varied, which may
b ed u et od i f f e r e n c ei na g ea sm a n yo ft h ec l i n i c a lf e a -
tures of LP only manifest fully with time. Both the
affected individuals showed initial symptoms during
infancy. The heterozygous parents and siblings revealed
no clinical signs and symptoms of LP upon detailed skin
examination.
Genotyping
Genotyping of two affected and five normal individuals
of the family (Figure 2A) was performed with microsa-
tellite markers (D1S2222, D1S3466, D1S498, D1S2347,
D1S2345) mapped in the region of ECM1 gene. The
markers were fully informative, and the results revealed
that the affected individuals were homozygous for the
markers suggesting linkage to the ECM1 gene.
Mutation analysis
The SSCP analysis revealed mobility shift bands in PCR
products of exon 6 of the ECM1 gene. Mutant allele was
found to be co-segregating with the disease phenotype in
the family. Both affected individuals (IV-1, IV-2) in the
family were homozygous for the mutant allele, while their
parents (III-1, III-2) and normal siblings (IV-3, IV-4, IV-5)
were heterozygous.
Direct sequencing of PCR products amplified from the
affected individuals revealed a homozygous C > T transi-
tion at nucleotide position 616 (c.616C > T) in exon 6 of
the ECM1 gene (Figure 2C). To see the effect of substitu-
tion on the coding sequence, the nucleotide sequence was
analyzed with CLC Workbench 4.0.2 software. The C > T
transition at nucleotide 616 changes the codon for
glutamine at amino acid position 206 into a stop codon (p.
Q206X), predicting premature termination of ECM1 with
205 amino acids instead of 540 amino acids of the normal
ECM1 protein. The mutation was confirmed by bidirec-
tional DNA sequencing. The parents and three normal
individuals of the family were heterozygous for the muta-
tion. To ensure that the mutation does not represent a
neutral polymorphism in the Pakistani population, 100
ethnically matched healthy control individuals were
screened for the mutation by PCR followed by direct
sequencing. The mutation was not identified outside the
family.
Discussion
The ECM1 gene comprises of 10 exons and encodes for
the extracellular matrix protein 1. There are four splice
variants including ECM1a, ECM1b and ECM1c, encoding
proteins of 540, 415 and 559 amino acids, respectively.
The recently described fourth splice variant comprises
transcription of 71 bp at the 3’ end of intron 1 and part of
exon 2 to give a truncated 57 amino acid protein [10].
ECM1 is a negative regulator of endochondral bone for-
mation, inhibiting alkaline phosphatase activity and miner-
alization [11]. It promotes angiogenesis, and shows over
expression in certain malignancies. It interacts with a vari-
ety of extracellular and structural proteins, contributing to
the maintenance of skin integrity and homeostasis [12-14].
The expression studies have demonstrated presence of
ECM1a within basal keratinocytes and ECM1b in supraba-
sal cells, suggesting a role for ECM1 in terminal keratino-
cyte differentiation [15].
Forty six mutations in the ECM1 gene have been
described so far in unrelated patients affected with lipoid
proteinosis (Table 1). These include 19 insertions/dele-
tions, 15 nonsense, 8 missense and 4 splice site mutations.
Both homozygous and compound heterozygous genotypes
have been reported. About half of all mutations (22 of 46)
are located within exon 6 or 7 (including adjacent splice
sites). Therefore, sequencing of these two exons has been
suggested as the initial step in efficiently determining the
molecular pathology in new cases of LP. Furthermore, as
previously reviewed by Chan et al 2007, there is no clear
paradigm for genotype phenotype correlation, considering
the type and position of the ECM1 gene mutations
reported so far. Most of the mutations in the ECM1 gene
are specific to individual families and only few are recur-
rent. In the present study, we identified a novel nonsense
mutation (Q206X) in exon 6 of the ECM1 gene in a con-
sanguineous Pakistani family. Five ECM1 mutations have
been previously reported in unrelated Pakistani LP families
(Table 1) and to our knowledge there is no report of
recurrent mutation. The Q206X mutation is predicted to
result in the increased degradation of both full-length
ECM1a and ECM1b transcripts due to nonsense mediated
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Page 3 of 6Figure 2 The LP family pedigree and DNA sequence analysis. (A) A multigenerational consanguineous Pakistani family in which lipoid
proteinosis (LP) is segregating as an autosomal recessive trait. (B) The electropherogram of an affected member revealed a homozygous C > T
transition at nucleotide position c.616 in exon 6 while father’s electropherogram revealed heterozygosity at the same position.
Table 1 Summary of the mutations in the ECM1 gene reported so far
Position Sequence
change
Mutation
type
Predicted
protein change
Patient origin Reference
Genotype: homozygous
Intron 1 IVS1+1G>C Splice site Removal of the translation initiation
site
Israeli Arab,
Kuwaiti, Egyptian
10, 17
Exon 2 c.93G>T Missense p.R31S Libyan 19
Exon 2 c.94 C>T Nonsense p.Q32X Libyan, Indian 17, 19
Exon 3 c.157 C>T Nonsense p.R53X Japanese 20, 21
Exon 3 c.220 C>T Nonsense p.Q74X Indian 17
Exon 4 c.243delG Deletion In-frame deletion of 61 amino acids Thai 20
Exon 5 c.340 C>T Nonsense p.Q114X Japanese 17
Exon 6 c.499 T>C Missense p.F167L Polish 22
Exon 6 c.501insC Insertion Frame shift Dutch, Belgian 2,23
Exon 6 c.507delT Deletion Frame shift Japanese, Thai, Indian, Canadian, Iranian, Turkish,
Pakistani, Chinese
17,20,23,24,
25,26
Exon 6 c.541del3ins16 Indel Frame shift Brazilian 27
Exon 6 c.589 C>T Nonsense p.Q197X Italian 28
Exon 6 c.629 T>C Missense p.L210P French 17
Exon 6 c.658 T>G Missense p.C220G Chinese 29, 30
Exon 7 c.727 C>T Nonsense p.R243X Belgian 31
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might be expressed stably leading to production of trun-
cated ECM1 protein. Although, functional consequences
of the premature termination codon mutations must be
established by northern blotting or quantitative reverse
transcriptase PCR, previous reports have not suggested
any difference in phenotype related to different mutation
genotypes. Premature stop codons in the last exon lead to
the presence of ECM1 truncated protein because the non
sense mediated mRNA decay is dependent on an
upstream exon-exon junction [16]. However, such patients
did not show a different or milder phenotype in compari-
son with cases with more upstream mutations [17,18].
Conclusions
We have identified a novel nonsense mutation in exon 6
of the ECM1 gene in a Pakistani family extending the
mutation spectrum of the gene. The study extends the
Table 1 Summary of the mutations in the ECM1 gene reported so far (Continued)
Exon 7 c.735delTG Deletion Frame shift Turkish 20
Exon 7 c.742 G>T Nonsense p.E248X Indian 32
Exon 7 c.785delA Deletion Frame shift Indian 20
Exon 7 c.806 G>A Missense p.C269T Saudi Arabian 33
Exon 7 c.826 C>T Nonsense p.Q276X South African 2
Exon 7 c.892delC Deletion Frame shift Japanese 20
Exon 7 c.1036 C>T Nonsense p.Q346X Pakistani 2
Exon 7 c.1077 G>A Nonsense p.W359X British 2, 17
Exon 7 c.1019delA Deletion Frame shift Kuwaiti 2
Intron 7 IVS7+1G>A Splice site Pakistani 17
Exon 8 c.1106 A>G Missense p.H369C Indian 17
Exon 8 c.1190insC Insertion Frame shift American 20
Exon 8 c.1209ins62 Insertion Frame shift Pakistani 34
Exon 8 c.1246 C>T Nonsense p.R416X Indian 17
Exon 8 c.1253delC Deletion Frame shift British 17
Exon 8 c.1300delAA Deletion Frame shift Saudi Arabian 17, 33
Intron 8 IVS8+1G>A Splice site Pakistani 17
Intron 8 -
Intron 10
IVS8_IVS10del Deletion Deleterious effect on protein structure
and function
Saudi Arabian 2, 33
Exon 10 c.1393delA Deletion Frame shift Israeli 18
Exon 10 c.1426 C>T Nonsense p.R476X Indian 17
Exon 10 c.1441 C>T Nonsense p.R481X Indian 17
Genotype: compound heterozygous
Exon 1 c.29 T>G Missense p.V10G Polish 17
Intron 1 IVS1+1G>A Splice site
Exon 3 c. 157 C>T Nonsense p.R53X Spanish 17
Exon 6 c.603delTG Deletion Frame shift
Exon 4 c.240delTC Deletion Frame shift German 18
Exon 7 c.1019delA Deletion Frame shift
Exon 4 c.283 C>T Nonsense p.Q95X British 17
Exon 10 c.1432delA Deletion Frame shift
Exon 6 c.480 G>A Nonsense p.W160X Canadian 20
Exon 6 c. 499 T>A Missense p.F167I
Exon 6 c.542insAA Insertion Frame shift Italian 20
Exon 7 c.727 C>T Nonsense p.R243X
Exon 6 c.543delTG/
ins15
Indel Frame shift Italian 35
Exon 7 c.727 C>T Nonsense p.R243X
Exon 6 c.658 T>G Missense p.C220G Chinese 36
Exon 10 c.1426 C>T Nonsense p.R476X
Exon 7 c.727 C>T Nonsense p.R243X Italian 17
Exon 7 c.735delTG Deletion Frame shift
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in the development of lipoid proteinosis. Identification
of pathogenic mutations in the ECM1 gene should be
helpful to improve genetic counseling and DNA based
prenatal diagnosis.
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